Immune dysregulation of diabetes in tuberculosis. Pei Min Thong

Semin Immunol. 2025 Apr 22;78:101959. doi: 10.1016/j.smim.2025.101959. Online ahead of print. ABSTRACT The rising prevalence of diabetes mellitus (DM) is undermining global efforts to eliminate tuberculosis (TB). Most studies found that patients with pulmonary TB and DM have more cavitary lung lesions, higher mycobacterial burden on the lungs, longer periods of infectiousness, and worse outcomes. … Read more

From immunobiology to intervention: Pathophysiology of autoimmune encephalitis. Marie A Homeyer

Semin Immunol. 2025 Apr 22;78:101955. doi: 10.1016/j.smim.2025.101955. Online ahead of print. ABSTRACT Autoimmune encephalitides (AEs) are neurological disorders caused by autoantibodies against neuronal and glial surface proteins. Nearly 20 years after their discovery, AE have evolved from being frequently misdiagnosed and untreated to a growing group of increasingly well-characterized conditions where patients benefit from targeted … Read more

Cellular stress and macrophage activation. Jing Yu

Semin Immunol. 2025 Apr 9;78:101953. doi: 10.1016/j.smim.2025.101953. Online ahead of print. ABSTRACT Cellular stress responses are pivotal in maintaining tissue homeostasis and intricately linked with various diseases. Macrophages, a key player of innate immune system, exhibit remarkable plasticity and responsiveness to environmental cues. In response to various cellular stresses, macrophages contribute to tissue homeostasis and … Read more

The stress and the alarmin-like cytokine interleukin-37 mediated extracellular and intracellular signal pathways. Yan Li

Semin Immunol. 2025 Apr 9;78:101952. doi: 10.1016/j.smim.2025.101952. Online ahead of print. ABSTRACT IL-37, as a member of the IL-1 cytokine family, has been extensively characterized as a critical immunoregulatory molecule that suppresses both innate and adaptive immune responses. This cytokine demonstrates constitutive and inducible expression patterns across various immune and non-immune cells in response to … Read more

Interplay between the complement system and other immune pathways in the tumor microenvironment. Cecilia Garlanda

Semin Immunol. 2025 Apr 9;78:101951. doi: 10.1016/j.smim.2025.101951. Online ahead of print. ABSTRACT Tumor growth and spread are sustained by the tumor microenvironment. Inflammatory cells and pathways have a fundamental role in the tumor microenvironment, driving or conditioning the functional activation of other leukocyte subsets and favoring evasion of anti-tumor immunity. One of the inflammatory pathways … Read more

Endogenous glucocorticoids and human immunity: Time to revisit old dogmas. Brinda Bhatt

Semin Immunol. 2025 Apr 8;78:101949. doi: 10.1016/j.smim.2025.101949. Online ahead of print. ABSTRACT Glucocorticoids (GCs) are steroid hormones with diverse and important roles in the physiologic response to stress. These include permissive and suppressive effects on immunity, which help prepare the organism for future infectious stressors and control the immunological response to a recent stressor, preventing … Read more

The role of the adaptive immune system in the initiation and persistence of multiple sclerosis. Ali Maisam Afzali

Semin Immunol. 2025 Apr 2;78:101947. doi: 10.1016/j.smim.2025.101947. Online ahead of print. ABSTRACT Multiple sclerosis (MS) is an inflammatory, demyelinating disease of the central nervous system (CNS) in which complex networks of interacting immune cells initiate and sustain the disease. The pathogenesis of relapsing MS is driven by adaptive immune cells that become activated outside the … Read more

Complement and the hallmarks of cancer. Mikel Rezola Artero

Semin Immunol. 2025 Apr 2;78:101950. doi: 10.1016/j.smim.2025.101950. Online ahead of print. ABSTRACT The hallmarks of cancer are a set of traits that normal cells acquire during their transformation into malignancy. Among the biological processes influencing these hallmarks, the innate immune complement system plays a critical role. It can operate canonically-in blood and tissues-via phagocytosis, inflammation, … Read more

Variable domain glycosylation as a marker and modulator of immune responses: Insights into autoimmunity and B-cell malignancies. Roxane Biersteker

Semin Immunol. 2025 Mar 29;78:101946. doi: 10.1016/j.smim.2025.101946. Online ahead of print. ABSTRACT Glycosylation of antibodies is essential for shaping immune responses, as it contributes significantly to antibody function and diversity. While immunoglobulin G (IgG) Fc glycosylation is well-characterized, variable domain glycosylation (VDG) introduces an additional and less understood layer of complexity. Notably, VDG is associated … Read more

Interferon regulatory factor 3 beyond innate immunity: Regulation in obesity and metabolic disorders. Heng Li

Semin Immunol. 2025 Mar 28;78:101948. doi: 10.1016/j.smim.2025.101948. Online ahead of print. ABSTRACT Interferon regulatory factor 3 (IRF3) is a transcription factor known primarily for its role in antiviral immunity via regulation of type I interferons (IFNs). Recent research has broadened its significance to encompass metabolic disorders, particularly obesity and diabetes. Obesity is characterized by chronic … Read more

deneme bonusu veren siteler - canlı bahis siteleri - casino siteleri casino siteleri deneme bonusu veren siteler canlı casino siteleri